Antenatal immunization

Figures & data

Figure 1. The period of vulnerability for infant infectious disease (ref. 11).

Figure 2. The recorded incidence of pertussis infection in the UK (ref. 1).

Figure 3. Laboratory confirmed pertussis cases and hospital admissions between January 2011 and June 2013, England only (ref. 1).

Figure 4. Cumulative cases of laboratory-proven influenza in infants whose mothers received influenza vaccine, as compared with control subjects (ref. 16).

Figure 5. Response to the question “How likely would you be to have a GBS vaccine in pregnancy?” (ref. 5).

Sanchez-Schmitz G, Levy O. Development of newborn and infant vaccines. Sci Transl Med 2011; 3:90ps27; http://dx.doi.org/10.1126/scitranslmed.3001880; PMID: 21734174

 PubMed Web of Science ®Google Scholar

Courtesy of G.Amirthalingam, 2013 Amirthalingam G, Gupta S, Campbell H. Pertussis immunisation and control in England and Wales, 1957 to 2012: a historical review. Euro Surveill. 2013;18(38). pii: 20587. a. CMO Annual Report 2011. Accessed at https://www.gov.uk/government/publications/cmo-annual-report-2011-volume-one-on-the-state-of-the-public-s-health

 Google Scholar

Zaman K, Roy E, Arifeen SE, Rahman M, Raqib R, Wilson E, Omer SB, Shahid NS, Breiman RF, Steinhoff MC. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med 2008; 359:1555 - 64; http://dx.doi.org/10.1056/NEJMoa0708630; PMID: 18799552

 PubMed Web of Science ®Google Scholar

McQuaid F, Jones C, Stevens Z, Plumb J, Hughes R, Bedford H, Heath PT, Snape MD. Attitudes towards vaccination against group B streptococcus in pregnancy. Arch Dis Child 2013; Forthcoming PMID: 24356806

 PubMed Web of Science ®Google Scholar